It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
HIV-infected babies given antiretroviral drugs in the first weeks of life were four times more likely to survive than those left untreated, raising hopes that more young lives can be saved, new research suggests.
The trial, involving 377 babies between 6 weeks and 12 weeks old, started in July 2005 in Soweto and Cape Town. Of those given the drugs early despite no sign of illness, 4 percent died over a 48-week period compared to 16 percent in the group where treatment was delayed until the babies showed signs of disease.